|
|
|||||||
| |||||||
| |||||||
| 1 | HOUSE JOINT RESOLUTION
| ||||||
| 2 | WHEREAS, In January 2005, the State of Illinois, through | ||||||
| 3 | its representatives in the Office of the Governor, signed a | ||||||
| 4 | $2.6 million contract with Ecosse Hospital Products Limited of | ||||||
| 5 | England for the purchase of 300,000 doses of influenza vaccine; | ||||||
| 6 | and
| ||||||
| 7 | WHEREAS, The start date on the contract was retroactive to | ||||||
| 8 | October 20, 2004; and | ||||||
| 9 | WHEREAS, The State of Illinois has not received the | ||||||
| 10 | contracted-for vaccine; and
| ||||||
| 11 | WHEREAS, In October 2004, the I-SaveRx program was created | ||||||
| 12 | to allow Illinois citizens to obtain prescription drugs through | ||||||
| 13 | a network of pharmacies in Canada, the United Kingdom, and | ||||||
| 14 | Ireland; and
| ||||||
| 15 | WHEREAS, In Executive Order 2003-15, the Governor | ||||||
| 16 | established a Special Advocate for Prescription Drugs; and
| ||||||
| 17 | WHEREAS, The Office of the Governor and the Special | ||||||
| 18 | Advocate for Prescription Drugs have been involved in the flu | ||||||
| 19 | vaccine procurement process and in the I-SaveRx and other | ||||||
| 20 | prescription drug programs; and
| ||||||
| 21 | WHEREAS, There are questions concerning the State's | ||||||
| 22 | obligation to pay on a contract for which the purchased goods | ||||||
| 23 | were not received and for which the State did not receive any | ||||||
| 24 | benefit; and
| ||||||
| 25 | WHEREAS, Enrollment in the I-SaveRx program has been low; | ||||||
| 26 | therefore, be it
| ||||||
| 27 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE | ||||||
| |||||||
| |||||||
| 1 | NINETY-FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, THE | ||||||
| 2 | SENATE CONCURRING HEREIN, that the Auditor General shall | ||||||
| 3 | conduct a management audit of the process followed in | ||||||
| 4 | negotiating and entering into the contract with Ecosse Hospital | ||||||
| 5 | Products Limited and in establishing and operating the I-SaveRx | ||||||
| 6 | program; and be it further
| ||||||
| 7 | RESOLVED, That the audit include, but not be limited to, | ||||||
| 8 | the following determinations:
| ||||||
| 9 | (1) The roles played by the Office of the Governor and | ||||||
| 10 | the Special Advocate for Prescription Drugs in negotiating | ||||||
| 11 | and entering into the flu vaccine contract;
| ||||||
| 12 | (2) The procedures applicable to, and agencies | ||||||
| 13 | responsible for, the establishment and operation of the | ||||||
| 14 | I-SaveRx program; and
| ||||||
| 15 | (3) Whether the entities involved in these programs | ||||||
| 16 | followed all applicable laws, regulations, policies, and | ||||||
| 17 | procedures; and be it further
| ||||||
| 18 | RESOLVED, That the Office of the Governor, the Office of | ||||||
| 19 | the Special Advocate for Prescription Drugs, and any other | ||||||
| 20 | entity that may have relevant information pertaining to this | ||||||
| 21 | audit cooperate fully and promptly with the Auditor General's | ||||||
| 22 | Office in the conduct of this audit; and be it further
| ||||||
| 23 | RESOLVED, That the Auditor General commence this audit as | ||||||
| 24 | soon as possible and report his findings and recommendations | ||||||
| 25 | upon completion in accordance with Section 3-14 of the Illinois | ||||||
| 26 | State Auditing Act.
| ||||||